Literature DB >> 20692533

Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages.

Carol El Chartouni1, Michael Rehli.   

Abstract

Interferon (IFN)gamma and interleukin (IL)-4 are central regulators of T helper 1 (Th1) and T helper 2 (Th2) immune responses, respectively. Both cytokines have a major impact on macrophage phenotypes: IFNgamma-priming and subsequent TLR4 activation induces so-called "classically activated" macrophages that are characterized by pronounced pro-inflammatory responses, whereas IL-4-treated macrophages, commonly called "alternatively activated", are known to develop enhanced capacity for endocytosis, antigen presentation and tissue repair and are generally considered anti-inflammatory. Considering IL-4 as priming rather than activating stimulus, we now compared the TLR4-dependent global gene activation program in IFNgamma- versus IL-4-pretreated mouse macrophages, which has rarely been studied so far. Although both cytokines frequently induced opposing effects on gene transcription, the subsequent activation of bone marrow-derived macrophages by lipopolysaccharide (LPS) produced a strong, priming-dependent pro-inflammatory response in both macrophage types. For example, the production of key pro-inflammatory cytokines IL-6 and IL-12 was significantly higher in IL-4- versus IFNgamma-primed macrophages and several cytokine genes, including Il19, Ccl17, Ccl22, Ccl24 and Cxcl5, were preferentially induced in "alternatively" primed and LPS activated mouse macrophages. In a subset of genes, including IL12a, IFNgamma-priming was actually found to suppress LPS-induced gene expression in a Stat1-dependent manner. Our data suggest that IL-4-priming is not per se anti-inflammatory but generates a macrophage that is "tissue protective" but still capable of mounting a strong inflammatory response after TLR4-dependent activation. Copyright 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692533     DOI: 10.1016/j.imbio.2010.05.032

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  20 in total

1.  Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells.

Authors:  Maria R Fernando; Mark A Giembycz; Derek M McKay
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

2.  AMP-activated protein kinase suppresses arachidonate 15-lipoxygenase expression in interleukin 4-polarized human macrophages.

Authors:  Dmitry Namgaladze; Ryan G Snodgrass; Carlo Angioni; Nina Grossmann; Nathalie Dehne; Gerd Geisslinger; Bernhard Brüne
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

3.  Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV.

Authors:  Ghantasala S Sameer Kumar; Abhilash K Venugopal; Manoj Kumar Kashyap; Rajesh Raju; Arivusudar Marimuthu; Shyam Mohan Palapetta; Yashwanth Subbanayya; Renu Goel; Ankit Chawla; Jyoti Bajpai Dikshit; Pramila Tata; H C Harsha; Jagadeesha Maharudraiah; Y L Ramachandra; Parthasarathy Satishchandra; T S Keshava Prasad; Akhilesh Pandey; Anita Mahadevan; S K Shankar
Journal:  J Proteomics Bioinform       Date:  2012-09-09

4.  Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury.

Authors:  Y Zhu; K Lyapichev; D H Lee; D Motti; N M Ferraro; Y Zhang; S Yahn; C Soderblom; J Zha; J R Bethea; K L Spiller; V P Lemmon; J K Lee
Journal:  J Neurosci       Date:  2017-01-27       Impact factor: 6.167

5.  Dissociation of endotoxin tolerance and differentiation of alternatively activated macrophages.

Authors:  Rajesh Rajaiah; Darren J Perkins; Swamy Kumar Polumuri; Aiping Zhao; Achsah D Keegan; Stefanie N Vogel
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

Review 6.  Macrophages make me sick: how macrophage activation states influence sickness behavior.

Authors:  Morgan L Moon; Leslie K McNeil; Gregory G Freund
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

7.  Expression of IFN-γ and IL-4 in the esophageal mucosa of patients with reflux esophagitis and Barrett's esophagus and their relationship with endoscopic and histologic grading.

Authors:  Ying-Qiang Zhong; Ying Lin; Zhe Xu
Journal:  Dig Dis Sci       Date:  2011-04-09       Impact factor: 3.199

8.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

9.  A combined omics study on activated macrophages--enhanced role of STATs in apoptosis, immunity and lipid metabolism.

Authors:  Ashok Reddy Dinasarapu; Shakti Gupta; Mano Ram Maurya; Eoin Fahy; Jun Min; Manish Sud; Merril J Gersten; Christopher K Glass; Shankar Subramaniam
Journal:  Bioinformatics       Date:  2013-08-26       Impact factor: 6.937

10.  p53 Integrates host defense and cell fate during bacterial pneumonia.

Authors:  Jennifer H Madenspacher; Kathleen M Azzam; Kymberly M Gowdy; Kenneth C Malcolm; Jerry A Nick; Darlene Dixon; Jim J Aloor; David W Draper; John J Guardiola; Maria Shatz; Daniel Menendez; Julie Lowe; Jun Lu; Pierre Bushel; Leping Li; B Alex Merrick; Michael A Resnick; Michael B Fessler
Journal:  J Exp Med       Date:  2013-04-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.